Jeffrey B. Mirviss

CIK: 0001566094

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (25.0%)

Position reduction

Option Exercises (M)5 (25.0%)

Derivative conversions

Awards (A)4 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (30.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CNMD

CONMED Corp

Director

BSX

BOSTON SCIENTIFIC CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

CNMD
CONMED Corp
Jul 1, 2026
Award(A)
RSUs (Restricted Stock Units)
Direct
5.6K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 25, 2025
Sale(S)
Direct
2.7K shares at avg. $104.00$280K
BSX
BOSTON SCIENTIFIC CORP
Feb 24, 2025
Sale(S)
Direct
4.7K shares at avg. $104.25$487K
BSX
BOSTON SCIENTIFIC CORP
Feb 19, 2025
Sale(S)
Direct
1.5K shares at avg. $105.35$159K
BSX
BOSTON SCIENTIFIC CORP
Feb 17, 2025
Tax Payment(F)
Direct
1.5K shares at avg. $106.11$161K
BSX
BOSTON SCIENTIFIC CORP
Feb 17, 2025
Exercise(M)
Direct
3.3K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 16, 2025
Tax Payment(F)
Direct
1.4K shares at avg. $106.11$144K
BSX
BOSTON SCIENTIFIC CORP
Feb 16, 2025
Exercise(M)
Direct
3K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 14, 2025
Tax Payment(F)
Direct
1.3K shares at avg. $106.11$134K
BSX
BOSTON SCIENTIFIC CORP
Feb 14, 2025
Exercise(M)
Direct
2.8K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 13, 2025
Award(A)
Restricted Stock Units
Direct
5.2K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
13.3K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 12, 2025
Exercise(M)
Direct
2.1K shares-
BSX
BOSTON SCIENTIFIC CORP
Feb 12, 2025
Tax Payment(F)
Direct
868 shares at avg. $105.77$92K
BSX
BOSTON SCIENTIFIC CORP
Feb 12, 2025
Sale(S)
Direct
13K shares at avg. $105.06$1.4M
BSX
BOSTON SCIENTIFIC CORP
Feb 11, 2025
Tax Payment(F)
Direct
10.7K shares at avg. $105.98$1.1M
BSX
BOSTON SCIENTIFIC CORP
Feb 11, 2025
Award(A)
Direct
23.8K shares-
BSX
BOSTON SCIENTIFIC CORP
Jan 3, 2025
Sale(S)
Direct
7.2K shares at avg. $89.86$643K
BSX
BOSTON SCIENTIFIC CORP
Jan 1, 2025
Exercise(M)
Direct
10.4K shares-
BSX
BOSTON SCIENTIFIC CORP
Jan 1, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $89.32$293K

		Type	Shares	Price		Ownership
Jul 1, 2026	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	5,603	-	-	Direct
Feb 25, 2025	BSX BOSTON SCIENTIFIC CORP	Sale(S)	2,688	$104.00	$279,552	Direct
Feb 24, 2025	BSX BOSTON SCIENTIFIC CORP	Sale(S)	4,675	$104.25	$487,369	Direct
Feb 19, 2025	BSX BOSTON SCIENTIFIC CORP	Sale(S)	1,510	$105.35	$159,079	Direct
Feb 17, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	1,521	$106.11	$161,393	Direct
Feb 17, 2025	BSX BOSTON SCIENTIFIC CORP	Exercise(M)	3,334	-	-	Direct
Feb 16, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	1,355	$106.11	$143,779	Direct
Feb 16, 2025	BSX BOSTON SCIENTIFIC CORP	Exercise(M)	2,970	-	-	Direct
Feb 14, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	1,266	$106.11	$134,335	Direct
Feb 14, 2025	BSX BOSTON SCIENTIFIC CORP	Exercise(M)	2,776	-	-	Direct
Feb 13, 2025	BSX BOSTON SCIENTIFIC CORP	Award(A) Restricted Stock Units	5,181	-	-	Direct
Feb 13, 2025	BSX BOSTON SCIENTIFIC CORP	Award(A) Stock Option (Right to Buy)	13,334	-	-	Direct
Feb 12, 2025	BSX BOSTON SCIENTIFIC CORP	Exercise(M)	2,115	-	-	Direct
Feb 12, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	868	$105.77	$91,808	Direct
Feb 12, 2025	BSX BOSTON SCIENTIFIC CORP	Sale(S)	13,022	$105.06	$1,368,073	Direct
Feb 11, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	10,738	$105.98	$1,138,013	Direct
Feb 11, 2025	BSX BOSTON SCIENTIFIC CORP	Award(A)	23,760	-	-	Direct
Jan 3, 2025	BSX BOSTON SCIENTIFIC CORP	Sale(S)	7,152	$89.86	$642,658	Direct
Jan 1, 2025	BSX BOSTON SCIENTIFIC CORP	Exercise(M)	10,430	-	$0	Direct
Jan 1, 2025	BSX BOSTON SCIENTIFIC CORP	Tax Payment(F)	3,278	$89.32	$292,791	Direct

1-20 of 20 transactions

About Mirviss Jeffrey B.

Mirviss Jeffrey B. (SEC CIK 0001566094) files insider reports with the SEC as Director of CONMED Corp (CNMD) and EVP&Pres, Periph Intervent of BOSTON SCIENTIFIC CORP (BSX).

Signal8 holds 8 ownership filings by Mirviss Jeffrey B. (1 Form 3, 7 Form 4), filed between Jan 3, 2025 and Jul 2, 2026. Those filings report 20 transactions, from Jan 1, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mirviss Jeffrey B.'s filings is in LARGO, FL.

Recent filings by Mirviss Jeffrey B.

Jul 1, 2026: Grant or award of CNMD derivative securities (Form 4, code A).
Feb 25, 2025: Open-market sale of BSX shares (Form 4, code S).
Feb 24, 2025: Open-market sale of BSX shares (Form 4, code S).
Feb 19, 2025: Open-market sale of BSX shares (Form 4, code S).
Feb 17, 2025: Tax withholding of BSX shares (Form 4, code F).

Other insiders filing for CONMED Corp (CNMD)

Kelderman Kim, Director
Gallagher John E, Executive Vice President & CFO
Martin Celine Christine, Director
Bronson David M., Director
Council LaVerne H, Director
Farkas Charles, Director

How to read Form 4 transaction codes